147 related articles for article (PubMed ID: 22935669)
1. The effects of intraocular silicone oil placement prior to iodine 125 brachytherapy for uveal melanoma: a clinical case series.
Ahuja Y; Kapoor KG; Thomson RM; Furutani KM; Shultz RW; Stafford SL; Dev S; Abu-Yaghi NE; Reynolds D; Pulido JS
Eye (Lond); 2012 Nov; 26(11):1487-9. PubMed ID: 22935669
[TBL] [Abstract][Full Text] [Related]
2. Delivered dose changes in COMS plaque-based ocular brachytherapy arising from vitrectomy with silicone oil replacement.
Morrison H; Larocque MP; Menon G; Sloboda RS; Weis E
Brachytherapy; 2019; 18(5):668-674. PubMed ID: 31272841
[TBL] [Abstract][Full Text] [Related]
3. Attenuation of iodine 125 radiation with vitreous substitutes in the treatment of uveal melanoma.
Oliver SC; Leu MY; DeMarco JJ; Chow PE; Lee SP; McCannel TA
Arch Ophthalmol; 2010 Jul; 128(7):888-93. PubMed ID: 20625051
[TBL] [Abstract][Full Text] [Related]
4. Iodine 125 brachytherapy with vitrectomy and silicone oil in the treatment of uveal melanoma: 1-to-1 matched case-control series.
McCannel TA; McCannel CA
Int J Radiat Oncol Biol Phys; 2014 Jun; 89(2):347-52. PubMed ID: 24721588
[TBL] [Abstract][Full Text] [Related]
5. 23-mm iodine-125 plaque for uveal melanoma: benefit of vitrectomy and silicone oil on visual acuity.
McCannel TA; Kamrava M; Demanes J; Lamb J; Bartlett JD; Almanzor R; Chun M; McCannel CA
Graefes Arch Clin Exp Ophthalmol; 2016 Dec; 254(12):2461-2467. PubMed ID: 27638702
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the shielding effectiveness of silicone oil vitreous substitutes when used with Palladium-103 and Iodine-125 eye plaques.
Yang YM; Chow PE; McCannel TA; Lamb JM
Med Phys; 2019 Feb; 46(2):1006-1011. PubMed ID: 30554429
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo dosimetry for 125I and 103Pd eye plaque brachytherapy with various seed models.
Thomson RM; Rogers DW
Med Phys; 2010 Jan; 37(1):368-76. PubMed ID: 20175499
[TBL] [Abstract][Full Text] [Related]
8. I-125 brachytherapy for choroidal melanoma photographic and angiographic abnormalities: the Collaborative Ocular Melanoma Study: COMS Report No. 30.
Boldt HC; Melia BM; Liu JC; Reynolds SM;
Ophthalmology; 2009 Jan; 116(1):106-115.e1. PubMed ID: 19118701
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric and late radiation toxicity comparison between iodine-125 brachytherapy and stereotactic radiation therapy for juxtapapillary choroidal melanoma.
Krema H; Heydarian M; Beiki-Ardakani A; Weisbrod D; Xu W; Laperriere NJ; Sahgal A
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(3):510-5. PubMed ID: 23507292
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and Safety of Low-Dose Iodine Plaque Brachytherapy for Juxtapapillary Choroidal Melanoma.
Oellers P; Mowery YM; Perez BA; Stinnett S; Mettu P; Vajzovic L; Light K; Steffey BA; Cai J; Dutton JJ; Buckley EG; Halperin EC; Marks LB; Kirsch DG; Mruthyunjaya P
Am J Ophthalmol; 2018 Feb; 186():32-40. PubMed ID: 29199010
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
12. Histopathologic characteristics of choroidal melanoma in eyes enucleated after iodine 125 brachytherapy in the collaborative ocular melanoma study.
Avery RB; Diener-West M; Reynolds SM; Grossniklaus HE; Green WR; Albert DM
Arch Ophthalmol; 2008 Feb; 126(2):207-12. PubMed ID: 18268211
[TBL] [Abstract][Full Text] [Related]
13. Alternative dose for choroidal melanoma treated with an iodine-125 radioactive plaque: a single-institution retrospective study.
Saconn PA; Gee CJ; Greven CM; McCoy TP; Ekstrand KE; Greven KM
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):844-8. PubMed ID: 20171804
[TBL] [Abstract][Full Text] [Related]
14. Factors predictive of radiation retinopathy post (125)Iodine brachytherapy for uveal melanoma.
Krema H; Xu W; Payne D; Vasquez LM; Pavlin CJ; Simpson R
Can J Ophthalmol; 2011 Apr; 46(2):158-63. PubMed ID: 21708084
[TBL] [Abstract][Full Text] [Related]
15. [Tyndallometry for follow-up of iodine-125 brachytherapy of uveal malignant melanomas. Report of 2 patients].
Nguyen NX; Küchle M; Strunk W
Klin Monbl Augenheilkd; 1996 Jul; 209(1):25-30. PubMed ID: 8965473
[TBL] [Abstract][Full Text] [Related]
16. Incidence of cataract and outcomes after cataract surgery in the first 5 years after iodine 125 brachytherapy in the Collaborative Ocular Melanoma Study: COMS Report No. 27.
Collaborative Ocular Melanoma Study Group
Ophthalmology; 2007 Jul; 114(7):1363-71. PubMed ID: 17337065
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of choroidal melanomas treated with eye physics plaques: A 25-year review.
Le BHA; Kim JW; Deng H; Rayess N; Jennelle RL; Zhou SY; Astrahan MA; Berry JL
Brachytherapy; 2018; 17(6):981-989. PubMed ID: 30082188
[TBL] [Abstract][Full Text] [Related]
18. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
19. (125)I episcleral plaque brachytherapy in the treatment of choroidal melanoma: a single-institution experience in Spain.
Correa R; Pera J; Gómez J; Polo A; Gutiérrez C; Caminal JM; Modolell I; Navarro V; Guedea F
Brachytherapy; 2009; 8(3):290-6. PubMed ID: 19428308
[TBL] [Abstract][Full Text] [Related]
20. Plaque radiotherapy for the management of uveal metastasis.
Shields CL; Shields JA; De Potter P; Quaranta M; Freire J; Brady LW; Barrett J
Arch Ophthalmol; 1997 Feb; 115(2):203-9. PubMed ID: 9046255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
